Resultados de procura - Balasubramaniam, Sanjeeve

Association between Benign Thyroid and Endocrine Disorders and Subsequent Risk of Thyroid Cancer among 4.5 Million U.S. Male Veterans por Balasubramaniam, Sanjeeve, Ron, Elaine, Gridley, Gloria, Schneider, Arthur B., Brenner, Alina V.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy por Jakopovic, Marko, Thomas, Anish, Balasubramaniam, Sanjeeve, Schrump, David, Giaccone, Giuseppe, Bates, Susan E.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Advancing Clinical Trials to Streamline Drug Development por Bates, Susan E., Berry, Donald A., Balasubramaniam, Sanjeeve, Bailey, Stuart, Rubin, Eric H., LoRusso, Patricia M.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Phase I/II Trial of Vandetanib and Bortezomib in Adults with Locally Advanced or Metastatic Medullary Thyroid Cancer por Del Rivero, Jaydira, Edgerly, Maureen, Ward, Jean, Madan, Ravi A., Balasubramaniam, Sanjeeve, Fojo, Tito, Gramza, Ann W.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Phase II Clinical Trial of Ixabepilone in Metastatic Cervical Carcinoma por Burotto, Mauricio, Edgerly, Maureen, Poruchynsky, Marianne, Velarde, Margarita, Wilkerson, Julia, Kotz, Herb, Bates, Susan, Balasubramaniam, Sanjeeve, Fojo, Tito

Ligazón do recurso Ligazón do recurso Ligazón do recurso

A population pharmacokinetic/toxicity model for the reduction of platelets during a 48-h continuous intravenous infusion of the histone deacetylase inhibitor belinostat por Peer, Cody J., Hall, Oliver M., Sissung, Tristan M., Piekarz, Richard, Balasubramaniam, Sanjeeve, Bates, Susan E., Figg, William D.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

A Phase II Multi‐Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma por Burotto, Mauricio, Edgerly, Maureen, Velarde, Margarita, Balasubramaniam, Sanjeeve, Drabkin, Harry, Gormaz, Juan G., O'Sullivan, Ciara, Madan, Ravi, Fojo, Tito

Ligazón do recurso Ligazón do recurso Ligazón do recurso

The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer por O'Sullivan, Ciara, Edgerly, Maureen, Velarde, Margarita, Wilkerson, Julia, Venkatesan, Aradhana M., Pittaluga, Stefania, Yang, Sherry X., Nguyen, Dat, Balasubramaniam, Sanjeeve, Fojo, Tito

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Continued tumor reduction of metastatic pheochromocytoma/paraganglioma harboring succinate dehydrogenase subunit B mutations with cyclical chemotherapy por Jawed, Irfan, Velarde, Margarita, Därr, Roland, Wolf, Katherine I., Adams, Karen, Venkatesan, Aradhana M., Balasubramaniam, Sanjeeve, Poruchynsky, Marianne S., Reynolds, James C., Pacak, Karel, Fojo, Tito

Ligazón do recurso Ligazón do recurso Ligazón do recurso

UGT1A1 Genotype-Dependent Dose Adjustment of Belinostat in Patients With Advanced Cancers Using Population Pharmacokinetic Modeling and Simulation por Peer, Cody J., Goey, Andrew K. L., Sissung, Tristan M., Erlich, Sheryl, Lee, Min-Jung, Tomita, Yusuke, Trepel, Jane B., Piekarz, Richard, Balasubramaniam, Sanjeeve, Bates, Susan E., Figg, William D.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Vaccine-Stimulated, Adoptively Transferred CD8(+) T Cells Traffic Indiscriminately and Ubiquitously while Mediating Specific Tumor Destruction por Palmer, Douglas C., Balasubramaniam, Sanjeeve, Hanada, Ken-ichi, Wrzesinski, Claudia, Yu, Zhiya, Farid, Shahram, Theoret, Marc R., Hwang, Leroy N., Klebanoff, Christopher A., Gattinoni, Luca, Goldstein, Allan L., Yang, James C., Restifo, Nicholas P.

Ligazón do recurso Ligazón do recurso

Effects of UGT1A1 Genotype on the Pharmacokinetics, Pharmacodynamics, and Toxicities of Belinostat Administered by 48-Hour Continuous Infusion in Patients With Cancer por Goey, Andrew K. L., Sissung, Tristan M., Peer, Cody J., Trepel, Jane B., Lee, Min-Jung, Tomita, Yusuke, Ehrlich, Sheryl, Bryla, Christine, Balasubramaniam, Sanjeeve, Piekarz, Richard, Steinberg, Seth M., Bates, Susan E., Figg, William D.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung por Balasubramaniam, Sanjeeve, Redon, Christophe E., Peer, Cody J., Bryla, Christine, Lee, Min-Jung, Trepel, Jane B., Tomita, Yusuke, Rajan, Arun, Giaccone, Giuseppe, Bonner, William M., Figg, William D., Fojo, Tito, Piekarz, Richard L., Bates, Susan E.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

An FDA Pooled Analysis of Patients with Melanoma Treated with an Anti-PD1 Antibody Beyond RECIST Progression por Beaver, Julia A., Hazarika, Maitreyee, Mulkey, Flora, Mushti, Sirisha, Chen, Huanyu, He, Kun, Sridhara, Rajeshwari, Goldberg, Kirsten B., Chuk, Meredith K., Chi, Dow-Chung, Chang, Jennie, Barone, Amy, Balasubramaniam, Sanjeeve, Blumenthal, Gideon M., Keegan, Patricia, Pazdur, Richard, Theoret, Marc R.

Ligazón do recurso Ligazón do recurso Ligazón do recurso

FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer por Arora, Shaily, Balasubramaniam, Sanjeeve, Zhang, Hui, Berman, Tara, Narayan, Preeti, Suzman, Daniel, Bloomquist, Erik, Tang, Shenghui, Gong, Yutao, Sridhara, Rajeshwari, Turcu, Francisca Reyes, Chatterjee, Deb, Saritas‐Yildirim, Banu, Ghosh, Soma, Philip, Reena, Pathak, Anand, Gao, Jennifer J., Amiri‐Kordestani, Laleh, Pazdur, Richard, Beaver, Julia A.

Ligazón do recurso Ligazón do recurso Ligazón do recurso